METHOD FOR IN VITRO SIMULATION AND EVALUATION OF PLATELET ADHESION IN BLOOD-CONTACTING MEDICAL DEVICES
20220015907 · 2022-01-20
Assignee
Inventors
Cpc classification
A61M60/237
HUMAN NECESSITIES
A61F2002/068
HUMAN NECESSITIES
A61F2/82
HUMAN NECESSITIES
A61M60/90
HUMAN NECESSITIES
A61M60/117
HUMAN NECESSITIES
A61M60/178
HUMAN NECESSITIES
G01N2021/646
PHYSICS
International classification
A61F2/24
HUMAN NECESSITIES
A61F2/82
HUMAN NECESSITIES
A61M60/117
HUMAN NECESSITIES
Abstract
A method for in vitro simulation and evaluation of platelet adhesion in blood-contacting medical devices is disclosed, including the following steps: (1) using a glycerin aqueous solution with a mass percentage concentration of 40% in an extracorporeal circulation circuit to simulate a viscosity and hydrodynamic characteristics of blood, and adding fluorescent particles with a diameter of 3 μm to 5 μm to the solution to simulate platelets; (2) after the solution circulates in the circuit for a specified time period, removing flow passage components of a tested device, and observing the deposition of the fluorescent particles on a blood-contacting surface inside the device by naked eyes and photographs; and (3) using laser-induced fluorescence (LIF) technique to apply laser light on a device surface deposited with the fluorescent particles and in contact with blood, and using charge-coupled device (CCD) camera imaging to photograph the aggregation and adhesion of laser-induced fluorescent particles.
Claims
1. A method for an in vitro simulation and an evaluation of platelet adhesion in a blood-contacting medical device, comprising the following steps: (1) using a glycerin aqueous solution with a mass percentage concentration of 40% in an extracorporeal circulation circuit to simulate a viscosity and hydrodynamic characteristics of blood, and adding fluorescent particles with a diameter of 3 μm to 5 μm to the glycerin aqueous solution to simulate platelets, to obtain a simulated blood solution; (2) after the simulated blood solution circulates in the extracorporeal circulation circuit for 24 h, removing flow passage components of the blood-contacting medical device, and observing a deposition of the fluorescent particles on a blood-contacting surface inside the blood-contacting medical device by naked eyes and photographs; and (3) using a laser-induced fluorescence (LIF) technique to apply laser light on the blood-contacting surface to obtain laser-induced fluorescent particles, wherein the blood-contacting surface is deposited with the fluorescent particles, and using a charge-coupled device (CCD) camera imaging method to photograph an aggregation and adhesion of the laser-induced fluorescent particles.
2. The method according to claim 1, wherein in the step (1), the fluorescent particles have a volume percentage concentration of 5% to 30% in the simulated blood solution.
3. The method according to claim 1, wherein the blood-contacting medical device is one selected from the group consisting of an artificial heart, a vascular stent and a mechanical valve.
4. The method according to claim 3, wherein for the vascular stent and mechanical valve, a traditional rotary pump is configured to achieve a circulation flow of the simulated blood solution in the extracorporeal circulation circuit; and for the artificial heart, the circulation flow of the simulated blood solution in the extracorporeal circulation circuit is achieved directly relying on power of the artificial heart.
5. The method according to claim 1, wherein when the deposition of the fluorescent particles does not occur after 3 days of an experiment, the blood-contacting medical device is removed, and the blood-contacting medical device is determined to have no structural deficiencies, wherein the structural deficiencies lead to the platelet adhesion.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0035] The present invention will be further illustrated below through examples, but the protection scope of the present invention is not limited by these examples.
[0036] As shown in
[0037] The experimental method of the present invention is as follows. A blood-contacting medical device is connected to the extracorporeal circulation circuit, and then fluorescent particles with a diameter of 3 μm to 5 μm are added to the solution to simulate platelets. The fluorescent particles have a concentration ranging from 5% to 30% in the solution. For non-powered devices such as a vascular stent and a mechanical valve, a traditional rotary pump may be used to achieve the flow of the solution in the circulation circuit; and for powered devices such as an artificial heart, the flow of the solution in the circulation circuit is achieved directly relying on their own power. After the solution circulates in the circuit for a specified time period, the deposition of fluorescent particles on a blood-contacting surface is observed. If there is significant deposition, flow passage components in the tested device are removed to observe the fluorescent particle deposition on the blood-contacting surface in the device by naked eyes and photographs. Then the LIF technique is used to apply laser light on the surface of the device that is in contact with blood and deposited with the fluorescent particles, and the aggregation and adhesion of fluorescent particles are observed in the CCD camera imaging through laser-induced fluorescent particles. If no fluorescent particle deposition occurs, the tested device is removed after the experiment is conducted for 3 days, and it is determined that there are no structural deficiencies in the device that can lead to significant platelet adhesion.
[0038] When blood-contacting medical devices are used in clinics, platelet adhesion occurs due to flow factors in the human body resulting from some structures of the devices. The method of the present invention can be used to locate a location and a structure in a device where platelet adhesion is most likely to occur. Therefore, the method can be used to guide the structural improvement of the device and can also be used for the registration test of the device's performance evaluation before the device goes on the market. The present invention provides a guiding method for analyzing which local structural deficiencies in the device will cause platelet adhesion and thrombosis, which is of great significance for the development of blood-contacting medical devices.
Example
[0039] Taking an artificial heart as an example, a simulated blood flow experiment is conducted on the type III axial flow blood pump model to evaluate the particle deposition and adhesion on the surfaces of a stator, a rotor, and a shell in the blood pump model. As shown in
[0040] The devices and materials used in the experiment are shown in the table below.
TABLE-US-00001 CCD camera B5M16 resolution: 2456*2058, acquisition rate: 1-8 HZ Lens NIKON 50 mm 1:1.4D Laser device model: Vlite-200 double-pulse laser, wavelength: 532 nm; single-pulse energy: 200 mJ; repetitive working frequency: 1-15 Hz Circulating rated power circulating water pump water pump Tracer fluorescent powder (magnesium arsenate, particles density: 1.34 g/cm.sup.3, average particle size: 5 μm) Workstation HpZ440, Intel(R) Xeon(R) CPU E5-1620 v4 @ 3.50 GHz Blood pump type III axial flow blood pump Color filter dedicated high-pass color filter, center wavelength: 560 nm Glycerin 1,2,3-propanetriol
[0041] Experimental process is as follows. 1) Glycerin and water are mixed at a concentration ratio of 4:6 to prepare a solution to simulate a blood viscosity. 2) The fluorescent powder is added to the prepared solution at a volume proportion of 20%, and a resulting mixture is thoroughly stirred until particles are evenly distributed. 3) The circulating water pump and blood pump model are connected, and then it is electrified to make the solution fully circulate. In the solution, the pump rotor is driven by the circulating water pump to rotate. 4) The circulating water pump drives the solution to flow through the blood pump, and particles will deposit on a model wall surface and the surfaces of the stator and rotor. 5) After the solution is circulated in the circuit for 24 h, the flow passage components of the tested device are removed to observe the deposition of the fluorescent particles on a blood-contacting surface inside the device by naked eyes and photographs. 6) In order to display the deposition effects on the wall surface of the model and the surfaces of the stator and rotor, the LIF method is used to irradiate the surface of the model with laser light, and the deposition effect of particles on the surface of the model is photographed. The fluorescent particles attached to the surface are induced by the laser light to produce light with a specific wavelength and thus imaged through the fluorescent color filter on the CCD camera, thereby observing the liquid adhesion on the rotor surface.
[0042] Experimental results are as follows. As shown in
[0043] It can be seen from the above results that the method of the present invention can locate a location and a structure in a device where platelet adhesion is most likely to occur, thus providing a guiding method for analyzing which local structural deficiencies in the device will cause platelet adhesion and thrombosis.